SBC Medical Group Holdings Incorporated (SBC)
NASDAQ: SBC · Real-Time Price · USD
3.560
+0.030 (0.85%)
Mar 13, 2026, 4:00 PM EDT - Market closed

SBC Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22
178.46205.42193.54174.16
Revenue Growth (YoY)
-20.10%6.13%11.13%-
Cost of Revenue
46.2349.3756.2459.33
Gross Profit
132.23156.05137.3114.83
Selling, General & Admin
57.657.6766.2370.65
Other Operating Expenses
0.2228.080.4124.06
Total Operating Expenses
57.8185.7566.6494.72
Operating Income
59.3670.370.6620.12
Interest Income
0.180.020.090.47
Interest Expense
0.120.030.050.03
Other Non-Operating Income (Expense)
10.143.162.883.12
Total Non-Operating Income (Expense)
10.443.213.013.62
Pretax Income
69.5673.4673.5823.68
Provision for Income Taxes
26.2426.7735.0218.12
Net Income
43.3246.6139.376.32
Minority Interest in Earnings
-0.010.08-0.81-0.76
Net Income to Common
43.3246.6139.376.32
Net Income Growth
-20.39%18.40%523.44%-
Shares Outstanding (Basic)
10397944
Shares Outstanding (Diluted)
10397944
Shares Change (YoY)
9.14%2.51%2540.76%-
EPS (Basic)
0.410.480.421.77
EPS (Diluted)
0.410.480.421.77
EPS Growth
-29.31%14.29%-76.28%-
Free Cash Flow
-37.0517.1741.15-24.99
Free Cash Flow Growth
--58.26%--
Free Cash Flow Per Share
-0.360.180.44-
Gross Margin
74.09%75.97%70.94%65.94%
Operating Margin
33.26%34.23%36.51%11.55%
Profit Margin
24.27%22.73%19.92%3.19%
FCF Margin
-20.76%8.36%21.26%-14.35%
EBITDA
62.374.182.9126.05
EBITDA Margin
34.91%36.07%42.84%14.96%
EBIT
59.3670.370.6620.12
EBIT Margin
33.26%34.23%36.51%11.55%
Effective Tax Rate
37.73%36.44%47.59%76.55%
Updated Nov 14, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q